Compare CVKD & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVKD | MNTS |
|---|---|---|
| Founded | 2022 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 20.3M |
| IPO Year | 2023 | N/A |
| Metric | CVKD | MNTS |
|---|---|---|
| Price | $7.12 | $7.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 82.1K | ★ 804.1K |
| Earning Date | 11-10-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,032,000.00 |
| Revenue This Year | N/A | $286.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.75 | $6.02 |
| 52 Week High | $22.90 | $183.86 |
| Indicator | CVKD | MNTS |
|---|---|---|
| Relative Strength Index (RSI) | 36.15 | 69.66 |
| Support Level | $6.75 | $0.44 |
| Resistance Level | $7.75 | $10.45 |
| Average True Range (ATR) | 1.00 | 0.84 |
| MACD | -0.22 | 0.76 |
| Stochastic Oscillator | 10.78 | 65.53 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.